Abstract:ObjectiveThe Asia Pacific Advanced Prostate Cancer Consensus Conference (APAC APCCC 2018) brought together 20 experts from 15 APAC countries to discuss the real-world application of consensus statements from the second APCCC held in St Gallen in 2017 (APCCC 2017). FindingsDifferences in genetics, environment, lifestyle, diet and culture are all likely to influence the management of advanced prostate cancer in the APAC region when compared with the rest of the world. When considering the strong APCCC 2017 recommendation for the use of upfront docetaxel in metastatic castration-naive prostate cancer, the panel noted possible increased toxicity in Asian men receiving docetaxel, which would affect this recommendation in the APAC region. Although androgen receptor-targeting agents appear to be well tolerated in Asian men with metastatic castration-resistant prostate cancer, access to these drugs is very limited for financial reasons across the region. The meeting highlighted that cost and access to contemporary treatments and technologies are key factors influencing therapeutic decision-making in the APAC region. Whilst lower cost/older treatments and technologies may be an option, issues of culture and patient or physician preference mean, these may not always be acceptable. Although generic products can reduce cost in some countries, costs may still be prohibitive for lower-income patients or communities. The panellists noted the opportunity for a coordinated approach across the APAC region to address issues of access and cost. Developments in technologies and treatments are presenting new opportunities for the diagnosis and treatment of advanced prostate cancer. Differences in genetics and epidemiology affect the side-effect profiles of some drugs and influence prescribing. ConclusionsAs the field continues to evolve, collaboration across the APAC region will be important to facilitate relevant research and collection and appraisal of data relevant to APAC populations. In the meantime, the APAC APCCC 2018 meeting highlighted the critical importance of a multidisciplinary team-based approach to treatment planning and care, delivery of best-practice care by clinicians with appropriate expertise, and the importance of patient information and support for informed patient choice.

Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011.

Management of Gastric Cancer in Asia: Resource-Stratified Guidelines

Updated epidemiology of gastrointestinal cancers in East Asia

Consensus Recommendations for Management of Head and Neck Cancer in Asian Countries: A Review of International Guidelines

Adaptation of International Guidelines for Metastatic Colorectal Cancer: an Asian Consensus.

Gastric Cancer in Asia: Unique Features and Management

Asian Consensus on the Relationship Between Obesity and Gastrointestinal and Liver Diseases

Management of patients with advanced prostate cancer in the Asia Pacific region: ‘real‐world’ consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017

Is There an Increasing Incidence of Gastroesophageal Junctional Adenocarcinoma and Barrett Esophagus in Asia? A Review of Diagnostic Conundrums

Management of patients with advanced prostate cancer in the Asia Pacific region: ‘real‐world’ consideration of results from the Advanced Prostate Cancer Consensus Conference <scp>(APCCC)</scp> 2017

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer

Multinational Survey on the Preferred Approach to Management of Barrett’s Esophagus in the Asia-Pacific Region

Gastroenterologists Should Play A Crucial Role in the Care of Patients with Digestive Cancers

Asia-Pacific Consensus on the Management of Gastro-Oesophageal Reflux Disease: an Update Focusing on Refractory Reflux Disease and Barrett'S Oesophagus

Clinical Management of Gastric Cancer: Results of a Multicentre Survey

Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor.

Asian Thoracic Oncology Research Group expert consensus statement on optimal management of stage III non-small cell lung cancer

Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009

Pan-Asian Adapted ESMO Clinical Practice Guidelines for the Management of Patients with Metastatic Oesophageal Cancer: a JSMO–ESMO Initiative Endorsed by CSCO, KSMO, MOS, SSO and TOS

A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives

Current Status of Diagnosis and Treatment of Colorectal Cancer in Asian Countries: A Questionnaire Survey